Illicit substance use among MSM and HIV in South America

Similar documents
References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS

References to Uruguay

Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES

BENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE. Steven P. Kurtz and Mance E. Buttram

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

TABLE 1 Annual Prevalence of Use for Various Types of Illicit Drugs, 2015 Among Full-Time College Students 1 to 4 Years beyond High School by Gender

CICAD. Report on Drug Use in the Americas Executive Summary INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

World Drug Report 2017

Patient Care Planning Group April 3, 2014

NIDA Quick Screen V1.0F1

World Drug Report 2018 Methodology Report. Research and Trend Analysis Branch UNODC, Vienna

Braz. Brazil. Mental Health and Drug Problems in Brazil 1/13/2014. Brazil. Dartiu Xavier da Silveira. Sao Paulo. January, 10, 2014

Drug Use Around the World

Cocaine Use among High School Students in Six South American Countries. Marya Hynes Dowell 1 Héctor Suárez 2 Francisco Cumsille 3

WORLD DRUG REPORT 2011

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Recent changes and new trends observed regarding drug use

Ecstasy and Related Drugs Reporting System drug trends bulletin April 2014

Section 3 Alcohol, Tobacco and Other Drug Use Measurement

Glencoe Health. Lesson 3 Psychoactive Drugs

Table of Contents VOLUME 1

WORLD DRUG REPORT 2004 WORLD DRUG REPORT. presented by Thomas Pietschmann UNODC, Research and Analysis Section

HIV and injecting drug use in the UK

STATISTICAL BULLETIN 2016

Alcohol, Tobacco, and Other Drugs: A Community Concern. Chapter 12

EMBARGOED UNTIL 22 JUNE PM CEST (GMT+2)

NIDA-Modified ASSIST Prescreen V1.0 1

Objectives 11/2/2016. Managing Patients with Substance Abuse. Off Label Disclosure. Steven Shoptaw, PhD Professor Department of Family Medicine, UCLA

High School and Youth Trends

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS. 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, November 2017

Lima - Peru, August 18-22, 2014

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

STATISTICAL BULLETIN 2015

Methodology World Drug Report 2017

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.

Economic and Social Council

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES

Author: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

Statement of the Executive Director UNODC on International Day against Drug Abuse and Illicit Trafficking

NIDA-Modified ASSIST - Prescreen V1.0*

London Chemsex Network Scoping meeting January 2017

The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends. ATS trends, programme progress and planned expansion

Polysubstance Use & Medication-Assisted Treatment

INFORMATION BRIEF. Illicit Drugs and Youth. Background

FACT SHEET 1 IRAN (ISLAMIC REPUBLIC OF)

Drug Abuse Trends Minneapolis/St. Paul, Minnesota

Course Catalog. Early Intervention, Treatment, and Management of Substance Use Disorders

Substance Abuse in US and Europe

9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.

Howard Abadinsky. St. John's University THOMSON + WADSWORTH. Australia Canada Mexico Singapore Spain United Kingdon United States

Special Topic: Drugs and the Mind

The OAS Report. Issue Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults.

FACT SHEET TAJIKISTAN (REPUBLIC OF)

KEY FINDINGS FROM THE 2005 MYRBS

Resilience, Traumatic Stress and Clinical Trial Outcomes among Young Adults with Complex Drug Use

Supplement to HIV and AIDS Surveillance (SHAS)

BASIC RESULTS AND METHODOLOGY OF SCHOOL SURVEYS ON DRUG USE CONT. STANDARD TABLE 02 LIFE TIME PREVALENCE:

Teen marijuana use tilts up, while some drugs decline in use

Part 1: 2013 Ontario Student Drug Use and Health Survey Results

PREFACE. Antonio Maria Costa Executive Director United Nations Office on Drugs and Crime

Close to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church

2012 Florida Youth Substance Abuse Survey

2014 Florida Youth Substance Abuse Survey

Chapter 12. Alcohol, Tobacco, and Other Drugs: A Community Concern

High School & Youth Trends

Global drug trends and sustainable development

Consumption of new substances with psychoactive effects (NSPE)

ADAI Research Brief SPOKANE COUNTY DRUG USE EPIDEMIOLOGY

National Institute on Drug Abuse

Queensland Chemsex Study : Results from a cross-sectional survey of gay and other homosexually active men in Queensland--substance use

Defining Drugs. Any substance which, when taken into the body, alters or modifies one or more body functions

1.1 Overview Evolution of the World Drug Problem

2016 Florida Youth Substance Abuse Survey

2016 Florida Youth Substance Abuse Survey

Campus-Community Strategies in Substance Use/Misuse and HIV Prevention Frances M. Harding Director SAMHSA s Center for Substance Abuse Prevention

DRUNK DRIVING AND DRUGGED PREVENTION MONTH

Prevalence of Marijuana Use among University Students in Bolivia, Colombia, Ecuador, and Peru

BASIC RESULTS AND METHODOLOGY OF SCHOOL SURVEYS ON DRUG USE CONT. STANDARD TABLE 02 LIFE TIME PREVALENCE:

World Drug Report 2008: Paraguay

The college will enforce the following regulations, regardless of the status of court decisions:

HIV/AIDS and Drug Use in the United States: A case for Strategic Planning

The rise in teen marijuana use stalls, synthetic marijuana use levels, and use of bath salts is very low

HIV/AIDS and Drug Use in the United States: A Domestic Agenda

Prevalence of substance use in lifetime, past year and past 30 days in British Columbia and other provinces of Canada from 2008 to 2012 (2)

NARCOTIC NOTES FLIPBOOK BY: PER:

Evidence-based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework

NIGHTLIFE QUESTIONNAIRE RECREATIONAL USEV7 core module / 2018

Responding to HIV & ZIKA in Brazil

Alcoholism And Addiction In The Elderly

The Caring Center of Wichita LLC. General Information Client Name:

FACT SHEET BOSNIA AND HERZEGOVINA

FACT SHEET SERBIA (REPUBLIC OF)

Industry Health & Safety Testing, Training & Prevention.

Patterns and Correlates of PrEP Drug Detection among MSM and Transgender Women in the Global iprex Study

Student Drug Use in LGL (2009)

Transcription:

Illicit substance use among MSM and HIV in South America Raquel B. De Boni, MD, MsC, PhD Instituto National de Infectologia Evandro Chagas/ FIOCRUZ Rio de Janeiro-Brazil HPTN Regional Meeting Lima, 2018

Outline Illicit substance use in South America (Argentina, Brazil and Peru) Epidemiology (last 5-10 years) Substance use and HIV Illicit substance use among MSM in Argentina, Brazil and Peru 1. What illicit substances are MSM using? 2. Do MSM use more illicit substances than hetero men? 3. When do MSM use substances? Chemsex? 4. Do MSM have substance use disorders (SUD)? 5. Is illicit substance use a risk for HIV infection among MSM? 6. Does the use affect HIV prevention measures? Summary on research gaps on the above questions

Substance use is driven by multiple factors, including drug market UNODC. World Drug Report-2017

EPIDEMIOLOGY OF SUBSTANCE USE DIFFERS ACROSS GEOGRAPHIC REGIONS AND TIME Table : 12-month illicit substance use in the Americas-2015 South America % (CI 95%) North America % (CI 95%) Cannabis 2.9 (2.8-3.0) 12.4 (12.3-12.4) Cocaine* 0.9 (0.75-0.96) 1.8 (1.73-1.88) Amphetamines** and prescription stimulants 0.25 (0.24-0.26) 1.9 (1.69-2.26) Ecstasy 0.16 (0.14-0.17) 0.9 (0.89-0.89) Opioids (opiates and prescription) 0.14 (0.06-0.49) 4.4 (4.1-4.5) Opiates 0.06 (0.03-0.21) 0.5 (0.43-0.5) Men and women, 12-65 years. *Cocaine includes cocaine salt, "crack" cocaine and other types such as coca paste, cocaine base, basuco, paco and merla.**includes amphetamines and methamphetamines Sources: United Nations Office on Drugs and Crime estimates based on annual report questionnaire data and other official sources.

SEDRONAR. Estudio Nacional em poblacion de 12 a 65 años, sobre consumo de sustâncias psicoactivas. Argentina, n=20,658, 2017. FIOCRUZ.III Levantamento Nacional sobre o uso de drogas pela população brasileira. Brasil, n=16,273, 2017.DEVIDA.IV Encuesta Nacional de Drogas em la Poblacion General de Peru, n=20,275, 2010. 12-month illicit substance use among general population from Argentina, Brazil and Peru Argentina % (CI 95%) Brazil %(CI 95%) Cannabis 7.8 (6.8-8.8) 2.5 (2.1-2.9) 1.0 Cocaine 1.5 (1.1-2.0) 0.9 (0.7-1.05) 0.4 Pasta base/paco or Crack 0.1 (0.01-0.3) 0.3 (0.2-0.4) 0.5 Amphetamines and prescription stimulants 0.1( 0.03-0.2) 0.3 (0.2-0.4) - Hallucinogens(LSD, peyote, mescaline, etc) 0.6 (0.3-0.9) 0.3 (0.1-0.4) - Ecstasy 0.3 (0.1-0.5) 0.15 (0.1-0.2) 0.0 Inhalants 0.1 (0.02-0.15) 0.2 (0.1-0.3) 0.1 Prescription opioids - 1.4 (1.1-1.7) - Heroin <0.02 0.05(0.0-0.1) <0.0 Any illicit 8.3 (7.2-9.3) 3.2 (2.8-3.6) 1.5 Peru %

% of people in treatment by first drug of abuse at admission Argentina Brazil Peru Cannabis 15.6% 14.2% 45.6% Cocaine 70.2% 64.9% 49.6% Inhalants 4.4% 8% 4% Notes * Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; ** Figures may reflect number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine. Sources : UNODC Annual Report Questionnaire (ARQ) ; Inter-American Drug Abuse Control Commission (CICAD)

HIV prevalence among cocaine users (general population)

HIV prevalence among cocaine users (general population) HIV among non-injecting cocaine users Argentina= 6.3% N=504, Clinical + non-clinical sample of non-injecting cocaine users from Buenos Aires (Rossi et al., 2008) Brazil = 4.97% (CI 95% 3.75-6.56) N=7381 crack users, time-location sampling (Bastos& Bertoni, 2014) Peru=?

12-month substance use according to HIV status in Brazil. III BNHS, 2015 Yes HIV No (%) (%) P-value (Rao- Scott adjustment) Alcohol 49.5 43.1 0.34 Tobacco 45.3 15.3 <0.01 Cannabis 10.5 2.5 0.06 Crack- cocaine 5.3 0.3 <0.01 De Boni et al. Preliminary data (Non-injected substance use and HIV status in the III Brazilian Household Survey on Substance Use - accepted to NIDA Forum 2018)

*RST =Rapid Screening Tool. De Boni et al. Is substance use associated with the cascade of care in Latin America?-PLoS One 2018 N=3343 PLWHA in CCASAnet sites from Argentina, Brazil, Chile, Honduras, Mexico and Peru

Substance use among MSM in Argentina, Brazil and Peru 1. What illicit substances are MSM using? 2. Do MSM use more illicit substances than heterosexual men? 3. When do MSM use substances?chemsex? 4. Do MSM have SUD? 5. Is illicit substance use a risk for HIV infection among MSM? 6. Does the use affect HIV prevention measures? Summary on research gaps on the above questions

1. What illicit substances are MSM using? Club drugs,als Hallucinogenics Inhalants/poppers 1 0 0 1 0 0 0 0 4.3 5 6 7 4 5 12 10 12 Peru.Young, 2016.WS, n=556 Peru. Ludford, 2013.CS, n=5148 Brazil. De Boni,2018.CS_PrEP,n=421 Brazil. Torres, 2018.WS, n=5065 Brazil. Rocha, 2013.RDS,n=3449 Argentina.Balan, 2013.RDS, n=500 Cocaine 0 0 3.2 14 23 30 Cannabis 0 0 10 31 33 45 Any illicit 0 8.9 16 43 70 0 10 20 30 40 50 60 70 80 Note: 0= Not available at the paper. Club drugs include ecstasy; ALS= Amphetamine-like stimulants. Cocaine include crack and pasta básica. Methods: RDS=respondent driven sampling; CS=cross-sectional convenience;ws= websurvey. Measures from prior year (12/6/3 months)

2. Do MSM use more illicit substances than hetero men? 12- month substance use by sexual orientation. III LNUD, Brazil. 2015 MSM %(SE) Hetero %(SE) Alcohol 78.1(5.2) 51.5(1.0) <0.001 Binge 45.6(6.5) 23.9(0.8) <0.001 Inhalants 3.2(2.3) 0.3(0.1) <0.001 Ecstasy 4.5(3.0) 0.2(0.1) <0.001 LSD 1.9(1.9) 0.3(0.1) 0.02 Cannabis 16.7(4.8) 3.9(0.4) <0.001 Cocaine 3.2(1.7) 1.3(0.2) 0.09 IDU lifetime 3.9(3.1) 0.5(0.1) 0.003 p-value (Rao-Scott adjsutment) *III LNUD= III Brazilian Household Survey on Substance Use. No statistically significant difference on the use of crack, ketamine, BZD, amphetamines and opioids. N= 6113 (5861 hetero and 87 MSM). MSM= homosexual/gay and bisexual Preliminary results.

3. When do MSM use substances? Chemsex? Illicit drugs before/at sex Alcohol before/at sex 7 4 6.5 15 20 20 21 28 37 45 56 0 20 40 60 Peru. Young, 2016.WS, n=516 Peru. Galea, 2017.CS, n=341 Peru.Delgado,2017.CS, n=1607 Peru.Deiss, 2013.TLS, n=738 Brazil. Cunha,2015. CS, clinical, n=391 Brazil. Cunha, 2014.CS, n=155 living w/hiv WS=websurvey; CS=cross-sectional; TLS=time-location sampling

4.Do MSM have SUD? Not everyone who uses psychoactive substances has a substance use disorder (SUD). Problems associated with the use DSM-IV Use Abuse Dependency CID-10 Use Hazardous/harmful use Dependency DSM-V Substance use disorders Light Moderate Severe No studies were found specifically evaluating illicit SUD among MSM from Argentina, Brazil and Peru in the last 5 years

Substance use disorders (12- months) among Gay, Bisexual, Hetero Men in the US NESARC(2004) Heavy Drinking Alcohol Use Disorder Drug Use Disorder Gay 18.1% 16.8%* 3.2%* Bisexual 16.4% 19.5%* 5.1%* Heterosexual 13.7% 6.1% 0.5% *Statistically significant differences between Gay/Het and Bisexual/Het McCabe SE et al., 2009, Addiction. 1333-45

5. Is illicit substance use a risk for HIV infection among MSM? Controversial results Montano et al, JAIDS, 2005: 7 countries, n=13,847 MSM, data from 1999-2002 Bautista et al, Sex. Transm.Infect, 2004: Same data: Distribution of cocaine use was different across countries, as well as the association with HIV

5. Is illicit substance use a risk for HIV infection among MSM?(cont.) Argentina. Segura et al., 2007: 327 MSM followed for 12 months: cocaine/su not associated with seroconversion Pando et al, 2003: 694 MSM, cross-sectional, 18% Illicit substance use, no association with HIV infection Brazil Silva et al., 2012: 1085 MSM, case control, 10% Illicit substance use. No association between Illicit Substance Use and incident HIV Peru Lama et al., 2006: 3280 MSM, snowball, cocaine before/at sex increased likelihood of HIV

6. Does the illicit substance use affect HIV prevention measures? Most studies found association of illicit substance use and condomless sex Argentina: Balan. AIDS & Behavior, 2013 Peru: Ludford et al. Plos One, 2013. Caceres et al. 2008; Clark et al., 2007 Brasil. Rocha et al. AIDS & Behavior, 2013 Is it related to intoxication? Exchange of sex for drugs/money?

6. Does the illicit substance use affect HIV prevention measures? PrEP Brasil AOR controlled for sociodemographics, sexual behavior, depression, receiving SMS, GI symptoms. Stimulant use =cocaine(powder, crack,paste) or amphetamines or club drugs (ecstasy, LSD, GHB and ketamine) in the prior 3 months. Grinsztejn et al., Lancet HIV, 2018

Summary research gaps Lack of data/details on the type of illicit substances MSM are using nowadays, and the context of substance use (chemsex?) Preliminary data on differences between substance use among MSM and hetero. No recent data on illicit SUD Do MSM have specific treatment demands? Cocaine/alcohol decrease condom use should PrEP be an option for all?

Acknowledgements HPTN SUSC LAPCLIN STD-AIDS team Beatriz Grinsztejn Brenda Hoagland Francisco I. Bastos Luciana Kamel Thiago Torres Grants CNPQ 310541/2017-4 CNPQ 476333/2013-0 FAPERJ 232309 SENAD TCD08/2014 CCASAnet/IeDEA (NIH: U01-AI069923CA) HPTN&ACTG (NIH 5UM 1AI069476) The HIV Prevention Trials Network is funded by the National Institute of Allergy and Infectious Diseases (UM1AI068619, UM1AI068613, UM1AI1068617), with co-funding from the National Institute of Mental Health, and the National Institute on Drug Abuse, all components of the U.S. National Institutes of Health.